Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit

Posted on June 4, 2026
By CNBC
0 Views
1 min read

This drugmaker is developing breakthroughs like an 'EpiPen for heart attacks.' The market has yet to give it credit

The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an "EpiPen for heart attacks."